[1]
“Association of Level III Axillary Lymph Node Positivity with Clinicopathological Characteristics in Breast Cancer”, J. Anal. Oncol., vol. 13, pp. 16–21, Nov. 2024, doi: 10.30683/1927-7229.2024.13.03.